Precision Therapeutics' ChemoFx�� Demonstrates Significant Role In Selection Of Chemotherapy Doublets In Non Small Cell Lung Cancer

treatment decisions based on the biological processes of each individual's cancer. Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offer an innovative...